Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin-dependent kinase 3 (CDK3) is a serine/threonine protein kinase that plays a role in cell cycle control, particularly at the G0-G1 and G1-S transitions. It requires interaction with cyclins for activation and can phosphorylate histone H1. Recent studies suggest it may have oncogenic properties and be involved in cancer progression. While it's a potential therapeutic target, current inhibitors primarily focus on other CDK family members.
CDK3 inhibitors (not specific, as most target other CDKs like 2/4/6/7/9)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin-dependent kinase 3.